CGD Policy Blogs

Initiative

Expert

 

AIDS Vaccine Trials a Success in India

According to Rediff, a new AIDS vaccine could be as little as 5 years away:

Upbeat at the successful completion of clinical trials of an HIV/AIDS vaccine on first 10 volunteers in Pune, the Indian Council of Medical Research on Wednesday said if things go right the antidote for the dreaded disease will be available in the market five years from now.

Balancing "Country Ownership" and MCA Priorities

Today Michael Phillips brought the MCA to the front page of the Wall Street Journal. His article was an in-depth look at the first MCA compact with Madagascar, and the national dynamics that ushered this particular compact into being. He opened the article from Antananarivo with this:

Combination Vaccine Produces Lower Immune Response

JAMA logoA combination vaccine developed to reduce the number of injections infants receive appears to provide less immunity than the vaccines administered individually, according to a study in the April 13 2005 issue of JAMA.

Jim P. Buttery and colleagues conducted a study to determine the immunogenicity and safety of a combination 9-valent pneumococcal-group C meningococcal conjugate candidate vaccine.

Bad Bugs No Drugs

IDSA logoThe Infectious Diseases Society of America has published a report, Bad Bugs No Drugs, which calls for a range of incentives to encourage greater R&D into antibiotics for infectious diseases.

Sanofi-Aventis on Access to Medicines

Jean-Francois Dehecq, Chairman and CEO of Sanofi-Aventis, set out the guiding principles of the group's policies on Access to Medicines at the BioVision conference.

The Group has identified 6 therapeutic areas for which concrete solutions can be envisioned: five curative therapeutic fields - malaria, leishmaniasis, sleeping sickness, tuberculosis and epilepsy - as well as the preventive field of vaccines.

UNAIDS Calls for Focus on Preventing AIDS

According to the Voice of America, the head of UNAIDS, Peter Piot, says spending for HIV/AIDS programs in developing countries has increased from $200 million to more than $6 billion over the last eight years. Though he calls this encouraging, Dr. Piot says the big challenge is to get countries to make long-term commitments to funding to halt the spread of AIDS.

A Broader View of Aid

Washington PostToday's Washington Post has an editorial calling for a broader view of aid, in which they argue that increased aid can be used in ways which do not face the risk of low absorption by developing countries, including financing research.

WHO Calls For Greater Vaccination

Africa needs more investment in research and manpower to boost vaccination rates that are less than half the global average, the director-general of the World Health Organization, Jong-Wook Lee, said on Wednesday.

He said:

Africa's vaccination coverage stood at around 30 percent, compared with a world coverage of more than 70 percent. The vaccines being used are also old. New investment is needed in research and development, but this is not really being done to a significant extent.

Pages